CIBC Bancorp USA’s ResMed RMD Stock Holding History

CIBC Bancorp USA’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.4M	Buy	+50,599	New	+$12.6M	0.02%	472
2025 Q3	$5.53M	Buy	+20,207	New	+$5.52M	0.03%	384

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CIBC Bancorp USA's RMD Position: Q1 2026 in Review

CIBC Bancorp USA opened a new position in ResMed (RMD) in Q1 2026: 50,599 shares worth $11.4M. The stake represents 0.02% of the portfolio and ranks #472 among its holdings. This is a return to the name: CIBC Bancorp USA previously reported a position in RMD as recently as Q3 2025.

CIBC Bancorp USA first reported a position in RMD in Q3 2025 and has held it in 2 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

CIBC Bancorp USA held 50,599 shares of ResMed worth $11.4M as of Q1 2026.
ResMed was a new CIBC Bancorp USA position in Q1 2026.
ResMed made up 0.02% of CIBC Bancorp USA's portfolio in Q1 2026, its #472 holding.
CIBC Bancorp USA first reported a position in ResMed in Q3 2025 and has held it in 2 quarters since.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on CIBC Bancorp USA's 13F filing for Q1 2026, filed 12 May 2026.